FactoryRegistry

Manufacturing of blood and blood derivatives, for human use

NAPCS COLLECTION CODE 2045625000

The U.S. Census Bureau recorded this product line in 1 US manufacturing industry in the 2022 Economic Census, as the most specific line that industry reported, where 37 establishments reported producing it.

That is a count of establishments by industry. It says how many establishments in each industry reported this product line; the Economic Census publishes these figures as industry totals and never as a list of plants. The largest share Census published for any one industry is 8.6% of that industry’s establishments.

Industries that reported it

IndustryEstablishmentsShare of industryIn the register
325414378.6%Facilities in this industry

Withheld means Census suppressed the figure because publishing it would disclose an individual establishment. The line itself is never suppressed — only the numbers on it.

Facilities in that industry

FactoryRegistry lists 909 facilities whose primary industry classification is one of the 1 industry above. This is a list by industry, not a list of makers: Census reports that establishments in these industries produced blood and blood derivatives, for human use, in the shares shown above, and does not say which establishments. Where a plant’s own website or a federal registry names what that plant makes, it appears on the plant’s own page with the source named.

Xoma (us) LLC
Berkeley, CA
UNVERIFIED325412
Xytogen Biotech
San Jose, CA
UNVERIFIED325414
Yenzym Antibodies LLC
South San Francisco, CA
UNVERIFIED325414
Zen Bio
Stockton, CA
UNVERIFIED325414
Ziegler Development CORP.
Berkeley, CA
UNVERIFIED325414
Zoetis, LLC
Charles City, IA
UNVERIFIED325414
Zoetis, LLC
White Hall, IL
UNVERIFIED325414
Zyagen
San Diego, CA
UNVERIFIED325414
Zymogenetics
Seattle, WA
UNVERIFIED325414

Part of Manufacturing of in-vitro diagnostic substances (clinical chemistry) reagents, standards and controls, including toxicology, blood bank, coagulation, virology, serology, cytology, etc. products, and culture media

The Economic Census files this product line under Manufacturing of in-vitro diagnostic substances (clinical chemistry) reagents, standards and controls, including toxicology, blood bank, coagulation, virology, serology, cytology, etc. products, and culture media. These are the other lines it groups:

Manufacturing of vaccines, toxoids, antigens, allergens, and other biologics, for human use (excluding diagnostic)

Related

Chemical ManufacturersAll product lines

Source for the product line, the establishment counts and the shares: U.S. Census Bureau, 2022 Economic Census (ECNNAPCSIND2022). Federal source data is public domain. Facility records are compiled separately by FactoryRegistry and carry their own sources.